Verus Pharmaceuticals Overview
- Year Founded
-
2002
- Status
-
Acquired/Merged
- Employees
-
10
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$310M
Verus Pharmaceuticals General Information
Description
Provider of solutions for the treatment of asthma, allergies, and related diseases and conditions. The company also offers Twinject, an epinephrine auto-injector for anaphylaxis. It is differentiated by its pediatric orientation and its strong financial position and experienced management team, which allows the company to capitalize on an extensive network to build its product portfolio and pursue complementary transactions.
Contact Information
Corporate Office
- 12671 High Bluff Drive
- Suite 200
- San Diego, CA 92130
- United States
Corporate Office
- 12671 High Bluff Drive
- Suite 200
- San Diego, CA 92130
- United States
Verus Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 24-Sep-2007 | $310M | Completed | Product Development | ||
| 1. Early Stage VC (Series A) | 10-Jun-2005 | Completed | Product Development |
Verus Pharmaceuticals Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
Verus Pharmaceuticals Signals
Verus Pharmaceuticals Former Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Athenian Venture Partners | Venture Capital | Minority | ||
| CDIB BioScience Venture Management | Venture Capital | Minority | ||
| Domain Associates | Venture Capital | Minority | ||
| Greenspring Associates | Venture Capital | Minority | ||
| MPM BioImpact | Venture Capital | Minority |
Verus Pharmaceuticals Investments (1)
Verus Pharmaceuticals’s most recent deal was a Corporate Asset Purchase with Hollister-Stier Laboratories (TwinJect Rights). The deal was made on 06-Jul-2005.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Hollister-Stier Laboratories (TwinJect Rights) | 06-Jul-2005 | Corporate Asset Purchase | Buildings and Property |
Verus Pharmaceuticals FAQs
-
When was Verus Pharmaceuticals founded?
Verus Pharmaceuticals was founded in 2002.
-
Where is Verus Pharmaceuticals headquartered?
Verus Pharmaceuticals is headquartered in San Diego, CA.
-
What is the size of Verus Pharmaceuticals?
Verus Pharmaceuticals has 10 total employees.
-
What industry is Verus Pharmaceuticals in?
Verus Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is Verus Pharmaceuticals a private or public company?
Verus Pharmaceuticals is a Private company.
-
What is the current valuation of Verus Pharmaceuticals?
The current valuation of Verus Pharmaceuticals is .
-
What is Verus Pharmaceuticals’s current revenue?
The current revenue for Verus Pharmaceuticals is .
-
How much funding has Verus Pharmaceuticals raised over time?
Verus Pharmaceuticals has raised $98M.
-
Who are Verus Pharmaceuticals’s investors?
Athenian Venture Partners, CDIB BioScience Venture Management, Domain Associates, Greenspring Associates, and MPM BioImpact are 5 of 9 investors who have invested in Verus Pharmaceuticals.
-
When was Verus Pharmaceuticals acquired?
Verus Pharmaceuticals was acquired on 24-Sep-2007.
-
Who acquired Verus Pharmaceuticals?
Verus Pharmaceuticals was acquired by AstraZeneca.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process